BACKGROUND: Significant progress has been made in understanding the molecular biology of ovarian carcinoma. Along with the molecular characteristics of cancer, the patient's response to the tumour may also contribute to survival; in particular, the effect of the immune system may play an important role on survival of cancer patients. PATIENTS AND METHODS: We analysed the CD3 positive tumour-infiltrating T cells and direct molecular assessment of T cell receptors (TCRs) gamma and beta in 95 advanced ovarian carcinomas. RESULTS: Gamma/delta T cells are statistically correlated with a brief disease-free interval (P=0.036). CD3 positive tumour-infiltrating T cells are correlated with a brief disease-free interval and with survival (P=0.004 and P=0.0001, respectively). CD3 positive tumour-infiltrating T cells are associated with clinical responsiveness to chemotherapy (P=0.003). CONCLUSIONS: Further studies are required to better understand the role of gamma/delta T cells in ovarian carcinoma, yet these data underline the importance of host immune response to cancer and the need to better study immune mechanisms to modulate the therapeutic treatment of cancer.
BACKGROUND: Significant progress has been made in understanding the molecular biology of ovarian carcinoma. Along with the molecular characteristics of cancer, the patient's response to the tumour may also contribute to survival; in particular, the effect of the immune system may play an important role on survival of cancerpatients. PATIENTS AND METHODS: We analysed the CD3 positive tumour-infiltrating T cells and direct molecular assessment of T cell receptors (TCRs) gamma and beta in 95 advanced ovarian carcinomas. RESULTS: Gamma/delta T cells are statistically correlated with a brief disease-free interval (P=0.036). CD3 positive tumour-infiltrating T cells are correlated with a brief disease-free interval and with survival (P=0.004 and P=0.0001, respectively). CD3 positive tumour-infiltrating T cells are associated with clinical responsiveness to chemotherapy (P=0.003). CONCLUSIONS: Further studies are required to better understand the role of gamma/delta T cells in ovarian carcinoma, yet these data underline the importance of host immune response to cancer and the need to better study immune mechanisms to modulate the therapeutic treatment of cancer.
Authors: Alena A Chekmasova; Thapi D Rao; Yan Nikhamin; Kay J Park; Douglas A Levine; David R Spriggs; Renier J Brentjens Journal: Clin Cancer Res Date: 2010-07-13 Impact factor: 12.531
Authors: Susan K Lutgendorf; Donald M Lamkin; Koen DeGeest; Barrie Anderson; Minh Dao; Stephanie McGinn; Bridget Zimmerman; Heena Maiseri; Anil K Sood; David M Lubaroff Journal: Brain Behav Immun Date: 2008-02-13 Impact factor: 7.217
Authors: Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Maryam B Lustberg; Alo Ray; Vincent J Pompili; Charles L Shapiro; Hiranmoy Das Journal: Int J Cancer Date: 2013-05-29 Impact factor: 7.396
Authors: Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson Journal: PLoS One Date: 2009-07-29 Impact factor: 3.240
Authors: M Stumpf; A Hasenburg; M-O Riener; U Jütting; C Wang; Y Shen; M Orlowska-Volk; P Fisch; Z Wang; G Gitsch; M Werner; S Lassmann Journal: Br J Cancer Date: 2009-09-29 Impact factor: 7.640